Histrelin implant and Moxetumomab pasudotox
Determining the interaction of Histrelin implant and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin implant-Moxetumomab Pasudotox-tdfk
- Histrelin implant-Moxetumomab pasudotox-tdfk Intravenous
- Histrelin implant-Moxifloxacin
- Histrelin implant-Moxifloxacin (Systemic)
- Histrelin implant-Moxifloxacin Hydrochloride
- Histrelin implant-Moxifloxacin Injection
- Moxetumomab pasudotox-Histrelin Implant (CPP)
- Moxetumomab pasudotox-Histrelin Implant (Prostate Cancer)
- Moxetumomab pasudotox-Histrelin Subcutaneous
- Moxetumomab pasudotox-Histuss PD
- Moxetumomab pasudotox-Hivid
- Moxetumomab pasudotox-Hizentra